Skip to content

Clinical trials

Retinal Vein Occlusion trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Clear all

274 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20025
20032
20044
20053
200611
20078
20084
200912
201014
201118
201220
201319
201411
201515
201611
20179
201814
201913
202013
202117
20229
20239
20244
202512
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed163
Unknown status53
Terminated24
Recruiting10
Not yet recruiting9
Active, not recruiting8
Withdrawn5
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals19
Allergan16
Bayer8
National Eye Institute (NEI)7
Assiut University4
Clearside Biomedical, Inc.4
Hoffmann-La Roche4
Medical University of Vienna4
Shahid Beheshti University of Medical Sciences4
Barnes Retina Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion274
Macular Edema113
Macular Degeneration56
Diabetic Retinopathy38
Vision Disorders17
Retinal Diseases15
Choroidal Neovascularization9
Retinal Artery Occlusion9
Glaucoma8
Wet Macular Degeneration8

Trials

Showing 26 to 50 of 274. Each trial links to its page on Pharma Observatory.

174 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.